Drug Type Biosimilar, Growth factors |
Synonyms Becaplermin Biosimilar (USV Pvt Ltd.), PDGF-BB(USV), 贝卡普勒明生物类似药(USV Pvt Ltd.) |
Target |
Action agonists |
Mechanism PDGFRβ agonists(Platelet-derived growth factor receptor beta agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic foot ulcer | Preclinical | India | 06 Jul 2025 |